Bangkok Tenofovir Study (BTS) Follow-Up
Status:Completed
Phase:Open Label
Principal Investigator(s):
Objective:Follow-on trial of daily oral TDF in men and women who inject drugs.
*Preliminary data reported in February 2015 showed that 35% of eligible participants decided to participate in the OLE, with a limited number of participants returning to the clinic suggesting the need for adherence support.*
Prevention Option(s):PrEP
Study Design:Open label
Official Code:
Bangkok Tenofovir Open Label follow-up Study
Trial Sponsors:
Bangkok Metropolitan Administration, CDC, Gilead
Start Date
End Date
none
none
Enrollment:0
Age range:
↔
any
Population:Cisgender Men, Cisgender Women, Injecting drug users